SWOG clinical trial number
SWOG-7629

Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinomas of the Head and Neck Region

Closed
Abbreviated Title
Cis-Diamminedichloroplatinum (II) in the Treatment of Refractory Epidermoid Carcinomas of the Head and Neck Region
Activated
10/29/1976
Closed
06/01/1978

Publication Information Expand/Collapse

1981

Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.

FJ Panettiere AACR, #623

Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.

FJ Panettiere AACR, #623

Cis-platinum (CACP) toxicity. An analysis based on 3 Southwest Oncology Group studies.

FJ Panettiere AACR, #623

1980

Cis-platinum therapy of previously treated head and neck cancer: The Southwest Oncology Group's two-dose per month outpatient regimen.

FJ Panettiere;D Lehane;W Fletcher;R Stephens;S Rivkin;JD McCracken Med & Ped Oncol 8:221-225

1979

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

Cis-dichlorodiammineplatinum (II) in adult patients: Southwest Oncology Group studies.

R Stephens;C Coltman;A Rossof;M Samson;F Panettiere;M Al-Sarraf;D Alberts;J Bonnet Cancer Treat Rep 63(9-10):1609-1610

1978

Effectiveness of new out patient program utilizing CACP in the chemotherapy of advanced epidermoid head and neck tumors.

FJ Panettiere;M Lane;D Lehane ASCO (#C-416)

Effectivenes of a two-dose regimen utilizing cis-diammine- dichloride platinum (II) in the treatment of refractory epidermoid carcinomas of the head and neck region. A Southwest Oncology Group study.

FJ Panettiere XIIth International Cancer Congress, Buenos Aires, Argentina, Vol. 2:190-191